ICICI Securities has issued a BUY recommendation for Karur Vysya Bank, maintaining a confident outlook despite macroeconomic stressors, particularly around exposure to US-exporting SME units.
Prabhudas Lilladher has initiated a BUY call on Ajanta Pharma, urging investors to seize this opportunity based on the company’s robust branded generics (BGx) franchise, promising financial perform